🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Elena A. Govorkova

St. Jude Children's Research Hospital

ORCID: 0000-0001-9067-5682
MedicineAgricultural and Biological SciencesImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
5.0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020

Antiviral Research(2022)10.1016/j.antiviral.2022.105281
Top 4%
5.0DataRank
Top 4%143 citations

Emi Takashita, Rod S. Daniels, Seiichiro Fujisaki, Lance Presser, Mira C. Patel +16 more

Papers

Driven by 22 papers — median percentile 96. Top paper: “Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020”.

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020

Antiviral Research(2022)10.1016/j.antiviral.2022.105281
Top 4%
5.0DataRank
Top 4%143 citations

Emi Takashita, Rod S. Daniels, Seiichiro Fujisaki, Lance Presser, Mira C. Patel +16 more

Characterizing Emerging Canine H3 Influenza Viruses

PLoS Pathogens(2020)10.1371/journal.ppat.1008409
N/A
0.998DataRank · unranked
46 citations

Pilar Blanco-Lobo, Laura Rodríguez, Theresa Fitzgerald, Hanyuan Zhang, Phuong Nguyen‐Contant +79 more

Multiple polymerase acidic (PA) I38X substitutions in influenza A(H1N1)pdm09 virus permit polymerase activity and cause reduced baloxavir inhibition

Journal of Antimicrobial Chemotherapy(2020)10.1093/jac/dkaa527
N/A
0.683DataRank · unranked
21 citations

Philippe Noriel Q. Pascua, Walter N. Harrington, Richard J. Webby, Elena A. Govorkova, Jeremy C. Jones

Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group

Antiviral Research(2021)10.1016/j.antiviral.2021.105158
N/A
0.564DataRank · unranked
42 citations

Frederick G. Hayden, Alan Hay, Larisa V. Gubareva, Elena A. Govorkova, Emi Takashita +2 more

Influenza A virus polymerase acidic protein E23G/K substitutions weaken key baloxavir drug-binding contacts with minimal impact on replication and transmission

PLoS Pathogens(2022)10.1371/journal.ppat.1010698
N/A
0.470DataRank · unranked
22 citations

Bogdan Zagribelnyy, Philippe Noriel Q. Pascua, Dmitry S. Bezrukov, Subrata Barman, Faten A. Okda +4 more

Rapid evolution of A(H5N1) influenza viruses after intercontinental spread to North America

Research Square(2022)10.21203/rs.3.rs-2136604/v1
N/A
0DataRank · unranked
11 citations

Christopher Patton, Jeremy C. Jones, Trushar Jeevan, Walter N. Harrington, Sanja Trifkovic +18 more

Rapid evolution of A(H5N1) influenza viruses after intercontinental spread to North America

Nature Communications(2023)10.1038/s41467-023-38415-7
N/A
0DataRank · unranked
241 citations

Christopher Patton, Jeremy C. Jones, Trushar Jeevan, Walter N. Harrington, Sanja Trifkovic +18 more

Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022–2023

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad418
N/A
0DataRank · unranked
32 citations

Jeremy C. Jones, Patrick Seiler, Ahmed Kandeil, Jasmine Turner, Subrata Barman +4 more

Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza A and B viruses

Antiviral Research(2023)10.1016/j.antiviral.2023.105701
N/A
0DataRank · unranked
5 citations

Jeremy C. Jones, Dmitrii O. Shkil, Yan A. Ivanenkov, Philippe Noriel Q. Pascua, Melissa K. Penaflor +4 more

Efficacy of oseltamivir treatment in influenza virus-infected obese mice

mBio(2023)10.1128/mbio.00887-23
N/A
0DataRank · unranked
6 citations

Jeremy C. Jones, Victoria Meliopoulos, Brandi Livingston, Bridgett Sharp, Leonardo D. Estrada +6 more

Highly pathogenic avian influenza A(H5N1) virus in a common bottlenose dolphin (Tursiops truncatus) in Florida

Research Square(2023)10.21203/rs.3.rs-3065313/v1
N/A
0DataRank · unranked
7 citations

Thomas Fabrizio, Robert J. Ossiboff, Christina Kackos, Trushar Jeevan, Jeremy C. Jones +17 more

Highly pathogenic avian influenza A(H5N1) virus in a common bottlenose dolphin (Tursiops truncatus) in Florida

Communications Biology(2024)10.1038/s42003-024-06173-x
N/A
0DataRank · unranked
54 citations

Thomas Fabrizio, Robert J. Ossiboff, Christina Kackos, Trushar Jeevan, Jeremy C. Jones +17 more

Genotypic and phenotypic susceptibility of emerging avian influenza A viruses to neuraminidase and cap-dependent endonuclease inhibitors

Antiviral Research(2024)10.1016/j.antiviral.2024.105959
N/A
0DataRank · unranked
20 citations

Jeremy C. Jones, Patrick Seiler, Ahmed Kandeil, Richard J. Webby, Elena A. Govorkova +1 more

Cross-species spill-over potential of the H9N2 bat influenza A virus

Nature Communications(2024)10.1038/s41467-024-47635-4
N/A
0DataRank · unranked
14 citations

John Franks, Ahmed Kandeil, Rebecca Badra, Jasmine Turner, Patrick Seiler +19 more

Genotype B3.13 influenza A(H5N1) viruses isolated from dairy cattle demonstrate high virulence in laboratory models, but retain avian virus-like properties

Nature Communications(2025)10.1038/s41467-025-61757-3
N/A
0DataRank · unranked
20 citations

Ahmed Kandeil, Walter N. Harrington, Jeremy C. Jones, Trushar Jeevan, Konstantin Andreev +13 more

Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020–2023

Antiviral Research(2025)10.1016/j.antiviral.2025.106217
N/A
0DataRank · unranked
17 citations

Adam Meijer, Elena A. Govorkova, Clyde Dapat, Larisa V. Gubareva, Ian Barr +20 more

Altered germinal center responses in mice vaccinated with highly pathogenic avian influenza A(H5N1) virus

Vaccine(2025)10.1016/j.vaccine.2025.127311
N/A
0DataRank · unranked
0 citations

Bryan S. Kaplan, David C. Brice, Susu Duan, Lei Li, Maureen A. McGargill +6 more

Baloxavir outperforms oseltamivir, favipiravir, and amantadine in treating lethal influenza A(H5N1) HA clade 2.3.4.4b infection in mice

Research Square(2025)10.21203/rs.3.rs-7768971/v1
N/A
0DataRank · unranked
0 citations

Konstantin Andreev, Jeremy C. Jones, Ahmed Kandeil, Peter Vogel, Richard J. Webby +1 more

Synthesis, inhibitory activity and oral dosing formulation of AV5124, the structural analogue of influenza virus endonuclease inhibitor baloxavir

Journal of Antimicrobial Chemotherapy(2020)10.1093/jac/dkaa524
N/A
0DataRank · unranked
15 citations

Oleg D. Mitkin, Jeremy C. Jones, Alexander V. Nikitin, Angela G. Koryakova, Рубен Карапетян +10 more

Characterizing Emerging Canine H3 Influenza Viruses.

Apollo (University of Cambridge)(2020)10.17863/cam.52579
N/A
0DataRank · unranked
0 citations

Pilar Blanco-Lobo, Laura Rodríguez, Theresa Fitzgerald, Hanyuan Zhang, Phuong Nguyen‐Contant +79 more

Effect of E23G/K, F36V, N37T, E119D, and E199G polymerase acidic protein substitutions on the replication and baloxavir susceptibility of influenza B viruses

Antiviral Research(2022)10.1016/j.antiviral.2022.105455
N/A
0DataRank · unranked
5 citations

Jeremy C. Jones, Richard J. Webby, Elena A. Govorkova, Philippe Noriel Q. Pascua

Influenza A virus polymerase acidic protein E23R substitution is a marker of reduced susceptibility to baloxavir

Antiviral Research(2022)10.1016/j.antiviral.2022.105369
N/A
0DataRank · unranked
8 citations

Samuel W. Rovito, Melissa K. Penaflor, Richard J. Webby, Elena A. Govorkova, Jeremy C. Jones